In order to assess the role of the gonads and anterior pituitary gland in the production of poor quality semen of males with homozygous sickle cell disease (SCD) serum gonadotrophins, namely follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin and serum testosterone, were assayed radioimmunologically in 33 men with sickle cell disease and in 29 age-matched normal control subjects.
Introduction
Delayed sexual maturation has been observed in children with sickle cell disease (SCD).' In 1981, we evaluated the fertility potential of men with SCD, but who were in stable state, by examining their semen. The mean sperm density was 18 x 106/ml; 18% were motile and 25% were well formed. In fact, no single semen sample of SCD patients met all the accepted minimum requirements for fertility. 2 These observations suggest that both spermatogenesis and androgenesis are defective in SCD patients. In order to determine whether these impaired functions are due to an intrinsic (primary) defect of the testis or secondary to failure of the hypothalamus/ pituitary gland, the serum gonadotrophins (follicle stimulating hormone (FSH) and luteinizing hormone (LH) prolactin and serum testosterone were assayed in these subjects. This paper reports our findings.
Patients and methods
Thirty three male patients with sickle cell disease (homozygous S and SC) whose ages ranged from 17 to 28 years with a mean of 20.2 (standard deviation 3.5) were studied. All the patients were in a clinically steady state and their haemoglobin (Hb) types were determined by cellulose acetate electrophoresis at pH 8.4.
Twenty nine males whose ages ranged from 18 to 27 years with a mean of 22.4 (s.d. 2.5) but without sickle cell disease served as controls (Table I) .
Twenty millilitres of blood were collected from each subject into lithium heparin bottles between 1000 hours and 1200 hours and serum was separated immediately and stored at -20°C until assayed.
Serum testosterone, FSH, LH and prolactin were measured by double antibody radioimmunoassay using reagents and standard sera from Radioassay Systems Laboratories, Carson, California. Samples from both groups were assayed in duplicate in one batch. The intra-and inter-assay coefficients of variation were 5.5-7.7% and 2.4-4.5% in the low and high range respectively. The results are recorded as mean and one standard deviation (s.d.) and statistical analyses were done by the Student's t test method.
Results
The results are summarized in Table I . The study groups were well matched for age and population size.
Eight SCD patients (24.4%) had raised serum FSH (range 22-70; mean 35.5, s.d. 16.9). In contrast none of the control subjects had a raised FSH. The mean level of the FSH in the SCD patients as a group was higher than that ofthe control group but the difference was not statistically significant (P > 0.1). Half of the patients (12%) with raised FSH had significantly raised LH (mean 31 ng/ml) and this was associated with low testosterone. The mean levels of LH in the two groups were however comparable (P > 0.05) ( Table I) . The mean testosterone level for the patients as a group was significantly lower than that of the controls. Four SCD patients (12%) had low serum testosterone levels of 2 -3 ng/ml.
The mean serum prolactin level was significantly higher in the patients than in the control group. About 40% of the SCD patients had serum prolactin levels in excess of the laboratory's upper limit of 20 ng/ml, compared with 10% in the control subjects.
In all, no single patient had depressed values of FSH, LH and prolactin.
Discussion
The basic mechanism through which SCD produces lesions such as splenic infarcts, necrosis of the femoral head and papillary necrosis, is vasoocclusion of small blood vessels by the sickled red blood cells. If this also accounts for the depressed reproductive capacity reported by us,2 gonadal dysfunction may be the result of vasoocclusion of either hypothalamic-pituitary blood vessles which would result in low serum gonadotrophins (FSH, LH, prolactin) and consequently low testosterone (secondary hypogonadism) or vasoocclusion of the testicular vessels resulting in target organ failure with low testosterone and high gonadotrophins (primary hypogonadism). It is also conceivable that vasoocclusion may affect both systems producing a complex of pituitary-testicular failure.
Our study shows that over 24% of adult SCD patients had high or severely elevated FSH. This means that these men have primary testicular failure. Furthermore, all 4 patients with low testosterone levels in this series had raised FSH and LH. This suggests that pituitary function was intact but that the testes were unable to respond to stimulation in these patients. It is also of interest to note that serum LH was normal in 50% of the patients with high FSH (seminiferous tubular failure). In other words, in half of the men who already showed hormonal evidence of seminiferous tubular failure, the Leydig cell function was normal. This suggests that the sperm producing cells were more susceptible to the damaging effect of SCD.
Olambinwonnu et al.,3 in a study of SCD children, reported that gonadal function was depressed in the first decade of life and reasoned that this was responsible for the delayed sexual maturation seen There does not appear to be any previous report ofthis hormone in SCD. The role of prolactin in spermatogenesis and steroidogenesis is at present unclear but hyperprolactinaemia is found in many infertile men.9 Whether the relationship is a cause or an effect or is a by-product -of one or the other is also not known. Masala et al.'0 strongly believe that hyperprolactinaemia can cause oligospermia but the effect on sperm quality of reduction to normal of raised prolactin in infertile males is disappointingly inconsistent.'0' 11 Some of the common causes of hyperprolactinaemia, e.g. drugs, renal failure, primary hypothyroidism, were excluded in our patients. Anterior pituitary tumour, another cause of raised serum prolactin was not radiologically excluded in our patients at the time of this study. It was however considered unlikely to occur in such a high proportion in a small population of patients. In spite of this it is our intention to investigate them for pituitary tumour later.
Even though these patients were in a steady state, it is difficult to exclude emotional stress (a potent cause of elevated serum prolactin) in a chronic disorder which imposes a lot of frustration and anxiety.
Although the cause of hyperprolactinaemia in these patients is unclear, the elevated values ofthis hormone as well as FSH and LH suggest that hypothalamicpituitary function is intact in these subjects and therefore unlikely to be the cause of the reduced fertility we had earlier observed in these patients. Dynamic studies with LHRH testing and hCG stimulators in a large, well controlled group of subjects in steady state of disease are desirable in order to further evaluate both hypothalamic-pituitary as well as testicular functions in SCD subjects. Such a study is being organized by the authors. 
